Lee Kyungmin, Go Gwangjun, Yoo Ami, Kang Byungjeon, Choi Eunpyo, Park Jong-Oh, Kim Chang-Sei
School of Mechanical Engineering, Chonnam National University, Gwangju 61186, Korea.
Korea Institute of Medical Microrobotics, Gwangju 61011, Korea.
Pharmaceutics. 2020 Jun 26;12(6):593. doi: 10.3390/pharmaceutics12060593.
Recently, significant research efforts have been devoted toward the development of magnetically controllable drug delivery systems, however, drug fixation after targeting remains a challenge hindering long-term therapeutic efficacy. To overcome this issue, we present a wearable therapeutic fixation device for fixing magnetically controllable therapeutic agent carriers (MCTACs) at defect sites and its application to cartilage repair using stem cell therapeutics. The developed device comprises an array of permanent magnets based on the Halbach array principle and a wearable band capable of wrapping the target body. The design of the permanent magnet array, in terms of the number of magnets and array configuration, was determined through univariate search optimization and 3D simulation. The device was fabricated for a given rat model and yielded a strong magnetic flux density (exceeding 40 mT) in the region of interest that was capable of fixing the MCTAC at the desired defect site. Through in-vitro and in-vivo experiments, we successfully demonstrated that MCTACs, both a stem cell spheroid and a micro-scaffold for cartilage repair, could be immobilized at defect sites. This research is expected to advance precise drug delivery technology based on MCTACs, enabling subject-specific routine life therapeutics. Further studies involving the proposed wearable fixation device will be conducted considering prognostics under actual clinical settings.
最近,人们在磁控药物递送系统的开发方面投入了大量研究精力,然而,靶向给药后的药物固定仍然是一个阻碍长期治疗效果的挑战。为了克服这个问题,我们提出了一种可穿戴治疗固定装置,用于将磁控治疗剂载体(MCTAC)固定在缺损部位,并将其应用于使用干细胞疗法的软骨修复。所开发的装置包括基于哈尔巴赫阵列原理的永磁体阵列和能够包裹目标身体的可穿戴带。永磁体阵列的设计,包括磁体数量和阵列配置,是通过单变量搜索优化和三维模拟确定的。该装置是针对给定的大鼠模型制造的,在感兴趣区域产生了强磁通密度(超过40 mT),能够将MCTAC固定在所需的缺损部位。通过体外和体内实验,我们成功证明了作为软骨修复的干细胞球体和微支架的MCTAC都可以固定在缺损部位。这项研究有望推动基于MCTAC的精确给药技术发展,实现针对个体的日常治疗。考虑到实际临床环境下的预后情况,将对所提出的可穿戴固定装置进行进一步研究。